HEmatology and Oncology journal cover August issue

A Rational Approach to the Development of Drug Combinations in Thoracic Oncology

D. Ross Camidge, MD, PhD

H&O  What is the typical approach to the development of drug combinations in oncology? DRC  In clinical trials, drug combinations can reflect several scenarios. A trial […]

From Recent Issues

Insights Into the Management of Older Patients With Multiple Myeloma

  H&O  What is the age distribution among patients with multiple myeloma? KA  Studies have shown that the median age of patients with multiple myeloma is […]

Risk Factors for and Clinical Management of Venous Thromboembolism During Pregnancy

  Abstract: Venous thromboembolism (VTE), which comprises deep vein thrombosis and pulmonary embolism, is one of the leading causes of non-obstetric maternal death in the United […]

Diagnosis and Treatment of Hemophilia

  Abstract: Hemophilia A and B are inherited bleeding disorders characterized by deficiency or dysfunction of coagulation protein factors VIII and IX, respectively. Recurrent joint and […]

Supplements

Advances in Aggressive Lymphoma From the 2019 American Society of Clinical Oncology Annual Meeting

  A Review of Selected Presentations From the 2019 ASCO Annual Meeting • May 31-June 4, 2019 • Chicago, Illinois Rituximab Maintenance for Patients With Diffuse […]

The Mechanism of Action of Regorafenib in Colorectal Cancer: A Guide for the Community Physician

Abstract: In 2012, the US Food and Drug Administration approved the kinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer who have been previously […]

Highlights in Chronic Lymphocytic Leukemia From the 2019 American Society of Clinical Oncology Annual Meeting

A Review of Selected Presentations From the 2019 ASCO Annual Meeting • May 31-June 4, 2019 • Chicago, Illinois Final Analysis From RESONATE: Six-Year Follow-Up in […]